-+ 0.00%
-+ 0.00%
-+ 0.00%

IRadimed Q1 FY26 GAAP EPS climbs 22% to $0.45; revenue rises 13% to $22 million

PUBT·05/01/2026 12:31:47
Listen to the news
IRadimed Q1 FY26 GAAP EPS climbs 22% to $0.45; revenue rises 13% to $22 million
  • Iradimed posts first-quarter 2026 net income of $5.8 million, up 24%.
  • Revenue rises 13% to $22 million.
  • Operating income climbs 33% to $7.2 million.
  • Commercial launch of next-generation 3870 MRI-compatible IV infusion pump draws strong early order activity, with larger order sizes than prior-generation platform.
  • Sees second-quarter revenue of $20 million-$21 million; reaffirms full-year revenue of $91 million-$96 million with GAAP diluted EPS of $1.9-$2.05.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IRadimed Corporation published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202605010830PRIMZONEFULLFEED9711246) on May 01, 2026, and is solely responsible for the information contained therein.